HAVCR2 and neoplasm: To evaluate the putative functional impact of TIM-3 expression, we monitored both IFN-γ and granzyme B expression by CD8+ TILs 3 days after a single anti-PD-1 injection and 10 days after tumor cell inoculation (Supplementary Fig. 11).